Tumor metastasis is the dominant cause of death in cancer patients, including oral squamous cell carcinoma (OSCC) patients. However, the molecular and cellular mechanisms underlying tumor metastasis are still elusive. The identification of molecular markers associated with the metastatic process would help understand biological mechanisms and facilitate the development of therapeutic interventions for OSCC patients. This proposal aims to test the hypothesis that serum proteomic markers can be used to stratify metastatic from non-metastatic oral cancers.
Two specific Aims are in place to test the hypothesis.
Aim 1 is to engage a quantitative proteomics platform, iTRAQ and 2-D LC-MS/MS, to harness serum signature proteins associated with lymph node metastasis of tongue SCC.
Aim 2 is to conduct AQUA validation of the candidate markers discovered in Aim 1 and build multi-marker prediction models for lymph node metastasis of tongue SCC. The overarching goal of the proposal is to discover serum proteomic markers and then translate the proteomic discoveries into prediction models that can forecast lymph node metastatic potential of primary tongue cancer, and thus improve clinical treatment decisions in the management of oral tongue cancer. This proposal will discover serum protein biomarkers for fast screening and assessment of lymph node metastasis of tongue cancer and improve clinical treatment of oral tongue cancer patients.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory/Developmental Grants (R21)
Project #
3R21CA122806-02S1
Application #
7848011
Study Section
Cancer Biomarkers Study Section (CBSS)
Program Officer
Jessup, John M
Project Start
2009-06-01
Project End
2009-10-31
Budget Start
2009-06-01
Budget End
2009-10-31
Support Year
2
Fiscal Year
2009
Total Cost
$20,377
Indirect Cost
Name
University of California Los Angeles
Department
Dentistry
Type
Schools of Dentistry
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Chai, Yang D; Zhang, Lifeng; Yang, Yan et al. (2016) Discovery of potential serum protein biomarkers for lymph node metastasis in oral cancer. Head Neck 38:118-25
Cui, Li; Cheng, Siliangyu; Liu, Xiaojun et al. (2016) Syntenin-1 is a promoter and prognostic marker of head and neck squamous cell carcinoma invasion and metastasis. Oncotarget 7:82634-82647
Yang, Yan; Huang, Junwei; Rabii, Bahareh et al. (2014) Quantitative proteomic analysis of serum proteins from oral cancer patients: comparison of two analytical methods. Int J Mol Sci 15:14386-95
Zhang, Min; Chai, Yang D; Brumbaugh, Jeffrey et al. (2014) Oral cancer cells may rewire alternative metabolic pathways to survive from siRNA silencing of metabolic enzymes. BMC Cancer 14:223
Misuno, Kaori; Liu, Xiaojun; Feng, Sizhe et al. (2013) Quantitative proteomic analysis of sphere-forming stem-like oral cancer cells. Stem Cell Res Ther 4:156
Hu, Shen; Gao, Kai; Pollard, Rodney et al. (2010) Preclinical validation of salivary biomarkers for primary Sjögren's syndrome. Arthritis Care Res (Hoboken) 62:1633-8
Hu, Shen; Jiang, Jiang; Wong, David T (2010) Proteomic analysis of saliva: 2D gel electrophoresis, LC-MS/MS, and Western blotting. Methods Mol Biol 666:31-41
Liu, Yi; Messadi, Diana V; Wu, Hongkun et al. (2010) Oral lichen planus is a unique disease model for studying chronic inflammation and oral cancer. Med Hypotheses 75:492-4
Hu, Shen; Zhou, Michael; Jiang, Jiang et al. (2009) Systems biology analysis of Sjögren's syndrome and mucosa-associated lymphoid tissue lymphoma in parotid glands. Arthritis Rheum 60:81-92
Arellano, Martha; Jiang, Jiang; Zhou, Xiaofeng et al. (2009) Current advances in identification of cancer biomarkers in saliva. Front Biosci (Schol Ed) 1:296-303

Showing the most recent 10 out of 15 publications